DEAFinal Rule
Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
HealthcareOther
Ad Space (leaderboard)
Summary
The DEA is allowing veterans to receive buprenorphine treatment (a medication used to treat opioid addiction) through telehealth appointments instead of requiring in-person visits at VA facilities. This makes it easier for veterans to access addiction treatment from home while maintaining continuity of care.
Key Points
- 1Veterans can now start and continue buprenorphine treatment through video or phone appointments with VA doctors
- 2The change removes barriers for veterans who have difficulty traveling to VA medical facilities or live in remote areas
- 3Buprenorphine is a controlled substance, so the DEA had to approve special rules allowing its prescription via telehealth for this population
- 4Doctors can conduct follow-up appointments remotely while still monitoring patient progress and safety
- 5This policy recognizes that many veterans struggle with opioid addiction and need accessible treatment options
Key Dates
Published
March 24, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)